|Day's Range||34.54 - 34.82|
|52 Week Range||20.73 - 35.26|
|PE Ratio (TTM)||96.44|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to QIAGEN NV Here are 5 ETFs with the largest exposure to QGEN-US. Comparing the performance and risk of QIAGEN NV with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis QIAGEN NV reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of QIAGEN NV – Thermo Fisher Scientific Inc., Genomic Health, Inc., Hologic, Inc., Becton, Dickinson and Company, General Electric Company, Trovagene, Inc., Bio-Techne Corporation and GenMark Diagnostics, Inc. (TMO-US, GHDX-US, ... Read more (Read more...)
QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.